US Patent Issued to Deciphera Pharmaceuticals on March 24 for "Methods of treating disorders using CSFIR inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,655, issued on March 24, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.).

"Methods of treating disorders using CSFIR inhibitors" was invented by Daniel L. Flynn (Waltham, Mass.), Bryan D. Smith (Waltham, Mass.), Rodrigo Ruiz Soto (Waltham, Mass.) and Keisuke Kuida (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods of treating cancers and other tumors related to the decreased proliferation, the depletion, or the repolarization of tumor-associated macrophages (TAMs) and treatment of associated disorders, including tenosynovial giant cell tumor (TGCT) and diffuse-type tenosynovial giant cell tumo...